Press Release
Manitoba Woman Beats Stage 4 Cancer with Breakthrough CAR T-Cell Therapy
–News Direct–
Disseminated on behalf of CERo Therapeutics Holdings, Inc.
Cancer treatments have come a long way over the years, but there is a newer treatment that is providing even stage four cancer patients with a new lease on life.
The first CAR T-cell therapy was only approved in 2017, but its already having a significant impact in the cancer treatment market. The latest success story comes from Sandra Hajlo, who just became the first person in Manitoba to be declared cancer-free following CAR T-cell therapy.1
Initially diagnosed with stage four B-cell lymphoma in 2015, Hajlo underwent successful chemotherapy. However, eight years later, her cancer returned, leading to another battle with the disease. After a misdiagnosis of scoliosis, a CT scan revealed her cancer had come back.
Her oncologist recommended CAR T-cell therapy, a new treatment where T-cells are modified to target cancer cells, making her the first recipient of this therapy at CancerCare Manitoba.
Dr. David Szwajcer, Manitoba Blood & Marrow Transplant Director at CancerCare Manitoba, explained that the CAR T-cells are collected, sent to a U.S. facility for modification, and then reintroduced to the patient. Hajlo described the procedure as quick and straightforward, taking only 20 minutes.
After undergoing CAR T-cell therapy in December 2023, Hajlo learned in April 2024 that the treatment was successful, and she is cancer-free once again, expressing her gratitude for the second chance at life.
CAR T-cell therapy does not guarantee survival, with about half of the patients not responding,but it has shown promising results in many cases.
CERo Therapeutics Holdings (NASDAQ:CERO) is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics. CERo Therapeutics is unrelated to CancerCare Manitoba and had no role in the CAR T-cell therapy described above. Nevertheless, CERo Therapeutics believes that the success of the CAR T-cell therapy in Manitoba may provide an indication of the potential for its proprietary CER-T (chimeric engulfment receptor) cell therapy.
CAR-T cell treatment has a steep price tag and some potential serious side effects including secondary cancer developing2 as well as cytokine release syndrome (CRS),3 which causes your immune system to go into overdrive and is potentially life threatening. CER-T cell therapy may provide a more cost-effective alternative with fewer side effects.
CERo Advances Innovative Cancer Immunotherapy
CERo Therapeutics (NASDAQ:CERO) developed CER-T cells to enhance efficiency and reduce side effects compared to traditional therapies by leveraging the body's natural tumor-fighting mechanisms. CER-T cells achieve this through direct tumor killing and by amplifying the body's anti-tumor immune response, and additionally by presenting cancer cell fragments to other immune cells, drawing these cells to attack the tumor.
Peer-reviewed data shows that CER-T cells have at least eight anticancer functions, offering potent, durable, and low-toxicity therapeutic benefits, with the capability to completely eliminate tumors. The company has validated these findings in 10 animal experiments, including a study on Acute Myeloid Leukemia (AML) published in March 2024.
CERo Therapeutics believes CER-T cells offer greater therapeutic potential than currently approved chimeric antigen receptor (CAR-T) cell therapy, potentially targeting both hematological malignancies and solid tumors. The company plans to begin clinical trials for its lead product candidate, CER-1236, in 2024 for treating hematological malignancies.
CERo has been diligently completing pre-clinical studies and documentation necessary to initiate clinical trials after gaining approval from the FDA for its Investigational New Drug (IND) Application.
CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) has successfully completed toxicity studies for CER-1236, a critical step before applying to the FDA for approval to begin human trials. With these studies showing that CER-1236 can be safely administered, the company is now focusing on ensuring safe manufacturing and finalizing its FDA application. Upon FDA acceptance, the company would be able to commence Phase 1 clinical trials, marking the start of the journey toward US approval and addressing unmet medical needs.
CERo plans to update shareholders on their progress, including presentations at investor conferences, potential growth of their intellectual property portfolio, and advancements in other programs beyond AML.
Click here for more information CERo Therapeutics Holdings, Inc., (NASDAQ:CERO).
Footnotes:
[1] https://globalnews.ca/news/10428035/manitobas-first-car-t-cell-therapy-patient-declared-cancer-free/
[2] https://jamanetwork.com/journals/jama/article-abstract/2815500
[3] https://www.pennmedicine.org/cancer/navigating-cancer-care/treatment-types/immunotherapy/what-is-car-t-therapy
Disclosure:
1) The author of the Article, or members of the authors immediate household or family, do not own any securities of the companies outlined in this Article. The author determined which companies would be included in this article based on research and understanding of the sector.
2) The Article was issued on behalf of and sponsored by, CERo Therapeutics Holdings, Inc. Market Jar Media Inc. was paid $1,500 USD for the production and publishing of this article by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.s engagement by CERo Therapeutics Holdings, Inc.s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-cero.
3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.
4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com.
5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.
6) This communication contains statements that are forward-looking and as such are not historical facts. This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations of CERo. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as anticipate, believe, continue, could, estimate, expect, intend, may, might, plan, possible, potential, predict, project, should, strive, would and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When CERo discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, CERos management. Actual results could differ from those implied by the forward-looking statements in this communication. Certain risks that could cause actual results to differ are set forth in CERos filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, filed on April 2, 2024, and the documents incorporated by reference therein. The risks described in CERos filings with the Securities and Exchange Commission are not exhaustive. New risk factors emerge from time to time and it is not possible to predict all such risk factors, nor can CERo assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking statements made by CERo or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. CERo undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of CERo Therapeutics Holdings, Inc. or such entities and are not necessarily indicative of future performance of CERo Therapeutics Holdings, Inc. or such entities.
8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation.
Contact Details
James Young
+1 800-340-9767
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/manitoba-woman-beats-stage-4-cancer-with-breakthrough-car-t-cell-therapy-472550199
MarketJar
COMTEX_453434643/2655/2024-06-06T08:32:55
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Karviva Wins Progressive Grocer Editor’s Pick Award as Brand Gains National Recognition and Retail Momentum
Saint Louis, Missouri, United States, 20th Apr 2026 – Karviva, the functional beverage brand founded by Dr. Angela Zeng, has been named a recipient of the 2026 Editor’s Pick Award by Progressive Grocer, one of the grocery retail industry’s leading trade publications. The recognition places Karviva among a select group of products identified for innovation, quality, and alignment with evolving consumer preferences.
The 22nd annual Editors’ Picks, announced by Progressive Grocer on April 8, 2026, highlight products shaping the future of food and beverage retail. This year’s selections emphasize functional nutrition, clean ingredients, global influences, and convenience-driven innovation. Karviva’s inclusion reflects growing demand for beverages that support everyday wellness while meeting modern lifestyle expectations.
Karviva develops plant-based functional juices designed to support hydration, digestion, energy, and metabolic balance. Founded by Dr. Zeng, the brand combines modern nutritional science with principles rooted in Traditional Chinese Medicine, focusing on whole-food ingredients and lower-sugar formulations rather than conventional juice cleanse approaches.
The recognition comes at a time when the functional beverage category is shifting toward more thoughtful formulations. Progressive Grocer noted that products incorporating adaptogens, plant-based nutrients, and functional ingredients are increasingly resonating with consumers seeking long-term wellness solutions rather than short-term trends.
Dr. Zeng has positioned Karviva within this shift by focusing on consistency, ingredient integrity, and daily usability.
“The goal is not to create extreme solutions, but to support the body in a way that fits into everyday life,” said Dr. Zeng. “Consumers are becoming more aware of what goes into their products, and they are looking for options that align with long-term health.”
The Editor’s Pick recognition follows a period of growing national visibility for Dr. Zeng and the Karviva brand. Most recently, Women’s World featured Dr. Zeng in an article titled “Dr. Angela Zeng Unites Ancient Wellness Principles and Modern Science,” highlighting her work in bridging traditional healing practices with contemporary nutritional research.
Karviva has also continued to expand its retail footprint across the United States. The brand’s products are now available in more than 1,000 retail locations, with recent launches in major grocery chains and regional markets contributing to its increasing national presence.
As consumers move toward products that prioritize function, transparency, and quality ingredients, Karviva’s recognition by Progressive Grocer reinforces its position within the next wave of functional beverage innovation.
With the Editor’s Pick award, continued media attention, and expanding retail distribution, Karviva enters 2026 with strong momentum across both industry and consumer markets.
About Karviva
Karviva is a St. Louis–based functional beverage company founded by Dr. Angela Zeng, PhD, MBA. The brand develops plant-based juices designed to support hydration, digestion, energy, and overall well-being. Rooted in both modern nutritional science and Traditional Chinese Medicine principles, Karviva focuses on clean ingredients, lower-sugar formulations, and products that fit into everyday routines. Karviva products are available through more than 1,000 retail locations across the United States and international markets.
Media Contact
Organization: Karviva
Contact Person: Dr. Angela Zeng
Website: https://karviva.com/
Email:
angela@karviva.com
City: Saint Louis
State: Missouri
Country:United States
Release id:44159
The post Karviva Wins Progressive Grocer Editor’s Pick Award as Brand Gains National Recognition and Retail Momentum appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
AetherCanvas Recently Launches Water Element Art Collection in North America
In 2026, art is taking shape in a groundbreaking new form. Asian heritage-driven art brand AetherCanvas officially announces the global launch of its 2026 Water Element Collection this April – a contemporary wall art series curated exclusively for the North American market.
The collection draws on traditional East Asian design philosophies, including the Five Elements framework, and adapts these influences into a modern visual language suited to current interior design preferences. The works focus on water-inspired forms, textures, and tonal compositions, offering an alternative to the increasingly warm and saturated color palettes seen in recent North American interiors.
AetherCanvas draws on the long-established principles of Feng Shui, which emphasize the relationship between spatial design, sensory experience, and environmental harmony.By translating these ancient ideas into modern, accessible wall art, the brand is redefining the role of art within everyday living environments in North America.
“Today’s North American homeowners seek art that does more than impress visually—they want meaning, cultural depth, and calm, balanced living spaces.” said Dennil, CEO of AetherCanvas, at the collection launch. “Eastern wisdom has long recognized the connection between our surroundings and our sense of harmony and well-being. With this Water Element Collection, AetherCanvas turns ancient spatial harmony into refined, modern art that seamlessly elevates North American homes.”
For AetherCanvas, art is an intentional presence that shapes the emotional architecture of a space. Each piece is designed to introduce balance, softness, and a refined atmospheric quality into the environments it inhabits.
In the living room, the water element artwork becomes a quiet visual anchor, softening social interactions while cultivating a sense of ease, warmth, and relaxation. In study areas, these pieces are intended to support a sense of clarity and focus, aligning with more mindful work routines. In the entryway or foyer, each piece establishes the first emotional impression of the home—subtly guiding the transition from the outside world into a more composed and intentional interior atmosphere.
The Balancing Role of the Water Element in 2026
2026 is associated with intensified “fire”, traditionally linked to heat, activity, emotional intensity, and strong outward expression.
Leading North American design authorities have described the year as a “Bold Warmth Era,” marked by the widespread use of saturated terracotta, burnt orange, and earthy tonal palettes across residential and commercial interiors. Mainstream interior styles further reinforce this shift toward warmth and saturation. Bohemian interiors embrace layered earth tones and organic warmth; Maximalism favors high-saturation contrasts and expressive color pairings; Pop-inspired spaces reintroduce bold, energetic palettes; while color-drenching trends immerse entire rooms in a single dominant hue.
Against this backdrop, AetherCanvas’s water element works provide a deliberate counterbalance, drawing from the Five Elements philosophy (the ancient Chinese system of wood, fire, earth, metal, and water that underpins Feng Shui) to offset visual intensity with calm and fluidity. They offer a strategic visual and emotional reset, bringing softness, depth, and equilibrium to otherwise high-energy environments.
AetherCanvas Integrates Water Element Design into Modern Spatial Art
AetherCanvas introduces its 2026 collection, inspired by the qualities of the water element – balance, fluidity, tranquility, and abundance – through a contemporary lens. The collection seeks to elevate residential and office spaces, not simply through aesthetic representation of water, but by creating artworks that complement and enhance the ambiance of modern interiors.
In this collection, water serves as a design motif that pairs harmoniously with other elements, particularly fire, to evoke a sense of calm and refinement. By aligning with the growing demand for thoughtfully curated living environments across North America, AetherCanvas’s pieces are designed to fit into today’s design trends, offering both beauty and a sense of calm in different settings.
These ideas are visual language suited to modern interiors, allowing the artworks to function as both refined design pieces and reflection of the spaces it inhabits.
Eastern Craftsmanship and Natural Materials in Contemporary Art
The 2026 Water Element Collection is crafted using carefully selected natural stone, handcrafted base forms, and traditional Eastern artisanal techniques. The collection will be available exclusively through AetherCanvas’s North American online store starting April 2026.
AetherCanvas draws on the heritage of Eastern craftsmanship, selecting premium materials rich in symbolic meaning. Each piece incorporates carefully chosen natural minerals, formed over millions of years, imparting a sense of permanence, stability, and tactile depth to the design. Handcrafted bisque textures add a distinctive material richness, preserving time-honored Eastern artistic techniques while infusing each work with a unique sense of craftsmanship and individuality.
These materials are valued not only for their appearance, but also for the stories they carry. Traditional craftsmanship techniques, preserved across generations, reinforce the brand’s emphasis on cultural continuity and artistic authenticity.
With the launch of its 2026 collection, AetherCanvas highlights a broader approach to how art can be incorporated into living and working environments across North America. The collection integrates personal aesthetics, cultural influences, and intentional spatial composition, reflecting a more immersive direction for wall art in 2026 and beyond.
In addition, AetherCanvas offers an optional online personalization tool designed to help users explore the relationship between personal characteristics and spatial elements, offering a reflective framework for understanding how art may influence atmosphere, mood, and spatial perception.
By combining natural materials, artisanal craftsmanship and design concepts, AetherCanvas develops pieces that bring a sense of balance and atmosphere to interior spaces.
Discover more AetherCanvas and explore its latest creations on:
Instagram(@senaura_art)
TikTok(@senaura_art)
Pinterest(@AetherCanvas).
About AetherCanvas
AetherCanvas is an art brand inspired by Feng Shui concepts, Five Elements philosophy, and contemporary wall art design. The brand is redefining the role of art in contemporary interior spaces with a forward-looking vision that establishes a new benchmark for spatial art within North American design. AetherCanvas also introduces its proprietary “Attraction Code,” a conceptual framework that translates invisible yet perceptible forces—such as energy, emotion, and atmosphere—into tangible visual expression.
Media Contact
Organization: AetherCanvas
Contact Person: Penelope Wong
Website: https://aethercanvas.art/
Email:
info@AetherCanvas.art
City: Los Angeles
State: CA
Country:United States
Release id:44083
The post AetherCanvas reinterprets spatial art through the lens of Eastern energy concepts appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Sihoo Doro C300 Pro V2 Is Officially Available: The Next Evolution in Full-Body Adaptive Ergonomics
Featuring the revolutionary DynaCore System, Sihoo’s newest flagship chair eliminates support loss during movement and delivers truly adaptive, personalized comfort.
Shenzhen, China, 20th Apr 2026 – Sihoo, a global leader in ergonomic furniture with 15 years of design and engineering excellence, today announced the official global availability of the highly anticipated Doro C300 Pro V2. Engineered to redefine all-day comfort, this new flagship model is the market’s first ergonomic chair to deliver true, intuitive, full-body adaptive support.
The End of Support Loss During Movement
Building on the global success of the original Doro C300, the Pro V2 sets a new standard for dynamic comfort. At its core is Sihoo’s proprietary DynaCore Full-Body Support System.
Unlike traditional office chairs that lose support the moment you move—or ergonomic chairs that demand constant readjustment—the Doro C300 Pro V2’s DynaCore system seamlessly synchronizes the backrest, lumbar support, headrest, and armrests. The result is a chair that intuitively responds to your natural movements. Whether you lean forward for focused work, shift side to side, or recline to relax, the chair maintains perfect, continuous balance.
Personalized Comfort from the First Moment
The Doro C300 Pro V2 takes personalization further with the SyncroFlex Backrest. The instant you sit down, the chair automatically maps and follows the natural curvature of your spine. Its intelligent recline path adapts dynamically to your unique body size and movement patterns, delivering a highly tailored experience with zero manual adjustments.
Next-Generation Features
The Doro C300 Pro V2 is packed with upgraded technology designed for today’s professionals, gamers, and creators:
- Self-Adaptive Dynamic Lumbar Support 2.0 — Offers three levels of targeted adjustability for fatigue-reducing lower-back support that lasts all day.
- 8D Bionic Armrests — Move in eight directions to provide perfect arm support whether you’re typing, gaming with a controller, or scrolling on a mobile device.
- Ultra-Wide 3D Headrest — Delivers precise, cradle-like neck support to relieve tension during long periods of focus.
- Weight-Adaptive Mechanism 2.0 — Automatically calibrates recline tension to your body weight, providing an ultra-smooth recline of up to 135° for a seamless transition between work and rest.
Availability
The Sihoo Doro C300 Pro V2 is now officially available in major global markets, including the United States, Germany, and France.
To purchase or learn more about its groundbreaking features, visit: https://sihoooffice.com/pages/sihoo-c300-pro-v2.
About Sihoo
Founded in 2011, Sihoo is driven by a core mission: to create seating solutions that seamlessly combine comfort, robust support, and cutting-edge ergonomic innovation. With 15 years of dedicated expertise in biomechanics and engineering, Sihoo has become a globally recognized brand trusted by modern businesses, remote workers, and households in more than 100 countries.
Media Contact
Organization: Sihoo
Contact Person: Wendy Xu
Website: https://sihoooffice.com/
Email: Send Email
City: Shenzhen
Country:China
Release id:44170
The post Sihoo Doro C300 Pro V2 Is Officially Available: The Next Evolution in Full-Body Adaptive Ergonomics appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Karviva Wins Progressive Grocer Editor’s Pick Award as Brand Gains National Recognition and Retail Momentum
AetherCanvas reinterprets spatial art through the lens of Eastern energy concepts
Sihoo Doro C300 Pro V2 Is Officially Available: The Next Evolution in Full-Body Adaptive Ergonomics
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release1 week ago
TARA BUI AND THE INTERCONTINENTAL SPRINGBOARD STRATEGY: EMPOWERING ASIAN MANUFACTURING GIANTS TO CONQUER THE U.S. MARKET
-
Press Release1 week ago
Smalth Titanium Lava Launches at 88 with Charging Case and Unique Lava Texture
-
Press Release1 week ago
LifeSafe Technologies Highlights Role in Trinity MPF Extinguisher Recognized at Tomorrow’s FM Awards
-
Press Release1 week ago
Smart Home Ahead Launches 2026 Survival Guide to End the 168 Billion Dollars Smart Home Frustration
-
Press Release1 week ago
Digital Smart AI Launches Scalable AI Solutions and GPU Rental Platform for Global Businesses
-
Press Release1 week ago
HerndonConnect.com Launches to Transform Local Business Discovery in Herndon, VA
-
Press Release3 days ago
Leadership That Delivers: How Jeffrey MacBride Is Redefining Project Management Excellence in High-Stakes Industries
-
Press Release1 week ago
BF Digital-Real Platform powers Web3 trading for seamless full-chain digital and physical asset flow